CompoAtlas

Oxyform IMMUNITE

Food supplement declared in France, declaration No 2021-8-1240

Oxyform IMMUNITE is a food supplement declared in France. Status: retrait du marché annoncé pour le 12 March 2027. 1 rule of use applies to its ingredients (limits and warnings).

Brand
not provided
Food business operator placing the product on the market
LABORATOIRES OXYFORM
Status
Retrait du marché annoncé pour le 12 March 2027
Form
Gélule
Daily dose
2 gélules
Directions for use
Prendre 2 gélules par jour avec un verre d’eau
Not recommended for (according to the manufacturer)
Femmes allaitantes, Enfants (moins de 12 ans), Femmes enceintes
Objectives stated by the manufacturer (these are not authorised claims)
Immunité

Declaration 260779, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Echinacea angustifolia DC.RacineExtrait fluide hydroalcoolique225 mg
Andrographis paniculata (Burm. f.) NeesParties aériennesExtrait sec hydroalcoolique200 mg
Thymus vulgaris L.FeuilleExtrait sec aqueux100 mg

Other active ingredients

NamePer day
Propolisnot declared

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
Bisglycinate de zincZinc25 mg15 mg

Additives

E551, E414, Hydroxypropyl Méthyl Cellulose, E470b

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

Ne pas dépasser la dose journalière indiquée. Ne se substitue pas à un régime alimentaire varié et équilibré ni à un mode de vie sain. Tenir hors de portée des jeunes enfants.Ne pas utiliser chez les femmes enceintes et allaitantes. Ne pas administrer à des enfants de moins de 12 ans.Les personnes sous traitement antidiabétique ou anticoagulant doivent consulter l'avis au préalable d'un professionnel de santé.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Other declarations with the same name

In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.

Enter to analyse, Shift+Enter for a new line